Join to View Full Profile
3601 21st Ave SNashville, TN 37232
Phone+1 615-322-3000
Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, 2008 - 2011
University of Alabama School of MedicineClass of 2008
Certifications & Licensure
TN State Medical License 2012 - 2026
AL State Medical License 2020 - 2020
NC State Medical License 2008 - 2011
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Impact of steroid dose and timing on efficacy of combination PD-1/CTLA-4 blockade.Nina B Curkovic, Rebecca Irlmeier, Xue Bai, Can Cui, Fei Ye
Oncoimmunology. 2025-12-01 - "Re-re-treatment?" Third and fourth courses of BRAF/MEK inhibition in advanced melanoma.Michael T O'Brien, Sage Iwamoto, Rizwan Haq, Douglas B Johnson
European Journal of Cancer. 2025-05-02 - Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.Eileen L Chang, Renee Liu, Kiandokht Keyhanian, Katie Huynh, Meghan Berkenstock
Journal for Immunotherapy of Cancer. 2025-04-08
Press Mentions
Skin Toxicities Can Persist for More Than a Year After Immune Checkpoint Inhibitor TherapyApril 17th, 2025- Study Provides Guidance on Immunotherapy-Related, Chronic Skin ReactionsApril 10th, 2025
- Chronic Skin Effects Persist After Cancer ImmunotherapyMarch 12th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
